Lina Han, PhD^1*, Qi Zhang^1*, Ce Shi, PhD^1,2*, Joel Leverson, PhD^3*, Monique Dail^4*, Darren C. Phillips, PhD^3*, Jun Chen, MD, PhD^3*, Sha S Jin^3*, Rodrigo Omar Jacamo, PhD^1*, Naval Daver, MD¹, Elias J Jabbour, MD¹, Hagop M Kantarjian, MD¹, Michael Andreeff, MD, PhD⁵, Deepak Sampath, PhD^4* and Marina Konopleva, MD, PhD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, First Affiliated Hospital, Harbin Medical University, Harbin, China
³AbbVie Inc., North Chicago, IL
⁴Genentech, South San Francisco, CA
⁵Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX

Stela Gengrinovitch, PhD^1*, Ruth Ben Yakar, PhD^1*, Tsila Zuckerman, MD^2,3*, Norberto Krivoy, MD^4* and Jacob M. Rowe, MD^2,3

¹BioSight Ltd., Karmiel, Israel
²Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
³Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
⁴Rambam Health Care Campus, Haifa, Israel

Gautam Borthakur, MD¹, Yishai Ofran, MD^2*, Arnon Nagler, MD, MSc³, Jacob M. Rowe, MD⁴, James M. Foran, MD⁵, Geoffrey L. Uy, MD⁶, John F. DiPersio, MD, PhD⁷, Jessica K. Altman, MD⁸, Olga Frankfurt, MD⁸, Martin S Tallman, MD^9*, Amnon Peled, PhD^10,11*, Yaron Pereg, PhD^12*, Abi Vainstein, MD^12*, Arnon Aharon, MD^12*, Ahmed AlRawi, PhD^1*, Teresa McQueen^13*, Naveen Pemmaraju, MD¹, Carlos E. Bueso-Ramos¹⁴, Jorge E. Cortes, MD¹⁵ and Michael Andreeff, MD, PhD¹⁶

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
³Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel
⁴Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
⁵Mayo Clinic Cancer Center, Jacksonville, FL
⁶Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁷Washington University School of Medicine, St Louis, MO
⁸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁹Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
¹⁰Biokine Therapeutics Ltd., Rehovot, Israel
¹¹Goldyne Savad Institute of Gene Therapy, Hebrew University Hospital, Jerusalem, Israel
¹²BioLineRx Ltd., Jerusalem, Israel
¹³Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Leukemia, MDACC, Houston, TX
¹⁵Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁶Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX

Eytan M. Stein, MD¹, Guillermo Garcia-Manero, MD², David A. Rizzieri, MD³, Raoul Tibes, MD, PhD⁴, Jesus G. Berdeja, MD⁵, Mojca Jongen-Lavrencic, MD, PhD⁶, Jessica K. Altman, MD⁷, Hartmut Dohner, MD⁸, Blythe Thomson, MD⁹, Stephen J. Blakemore, PhD^9*, Scott Daigle^9*, Greg Fine, MS^9*, Nigel J. Waters, PhD^9*, Andrei V Krivstov, PhD^1*, Richard Koche, PhD^1*, Scott A. Armstrong, MD, PhD¹⁰, Peter T Ho, PhD, MD⁹, Bob Lowenberg, MD, PhD⁶ and Martin S Tallman, MD¹¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Dept. of Medicine, Div. of Hematological Malignancies & Cellular Therapy, Duke University Medical Center, Durham, NC
⁴Mayo Clinic Scottsdale Arizona, Scottsdale, AZ
⁵Sarah Cannon Research Institute, Nashville, TN
⁶Erasmus University Medical Center, Rotterdam, Netherlands
⁷Northwestern University, Chicago, IL
⁸University Hospital of Ulm, Ulm, Germany
⁹Epizyme, Inc, Cambridge, MA
¹⁰Memorial Sloan-Kettering Cancer Center, New York, NY
¹¹Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Jo Ishizawa, MD, PhD^1*, Rodrigo Omar Jacamo, PhD^2*, Kensuke Kojima, MD, PhD^1,3*, Dhruv Chachad, MS^2*, Vivian Ruvolo, MS^4*, Peter Ruvolo, PhD², Weiguo Zang, PhD^1*, Yoko Tabe, MD, PhD¹, Marina Konopleva, MD, PhD¹, William Devine, PhD^5*, Susan Lindquist, PhD^6*, John A Porco Jr.^5*, Luke Whitesell, MD, PhD^6* and Michael Andreeff, MD, PhD¹

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
²Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Hematology, Respiratory Medicine and Oncology, Department of Medicine, Saga University, Saga, Japan
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Chemistry, Boston University, Boston
⁶Whitehead Institute for Biomedical Research, Cambridge

Jacalyn Rosenblatt, MD^1,2, Richard M. Stone, MD³, Lynne Uhl, MD¹, Donna Neuberg, ScD⁴, Poorvi Somaiya^1*, Dina Stroopinsky, PhD^1*, Robin Joyce, MD², James D. Levine, MD¹, Jon E. Arnason, MD¹, Katarina Luptakova, MD¹, Malgorzata McMasters, MD^1*, Salvia Jain, MD^1,5, David P. Steensma, MD⁴, Daniel J. DeAngelo, MD, PhD³, Ilene Galinsky, ANP³, Aya Sato-Dilorenzo, RN, BSN, OCN^1*, Kristen Anna Palmer^1*, Emma Logan^1*, Mary Paty Bryant^1*, Donald Kufe, MD^4* and David Avigan, MD¹

¹Beth Israel Deaconess Medical Center, Boston, MA
²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Malignant Hematology and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Daniel J. DeAngelo, MD, PhD¹, Amir T. Fathi, MD², Lillian Werner^2*, David E. Avigan, MD³, Katarina Luptakova, MD⁴, Martha Wadleigh, MD⁵, David P. Steensma, MD¹, Gabriela Soriano Hobbs, MD², Eyal C. Attar, MD², Philip C. Amrein, MD², Richard M. Stone, MD¹ and Karen K. Ballen, MD²

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Massachusetts General Hospital, Boston, MA
³Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁴Beth Israel Deaconess Medical Center, Boston, MA
⁵Dana-Farber Cancer Institute, Boston, MA

Masahiro Marshall Nakagawa^1*, Aruna Kode^1*, Sanil J Manavalan^2*, Govind Bhagat, MD³, Julie Teruya-Feldstein, MD⁴, Azra Raza, MD⁵, Ellin Berman, MD⁶ and Stavroula Kousteni⁷

¹Physiology/Cellbiophysics, Columbia University, New york, NY
²Columbia University, New york, NY
³Pathology and Cell Biology, Columbia University, New york, NY
⁴Icahn School of Medicine at Mount Sinai, New York, NY
⁵Columbia University Medical Center, New York, NY
⁶Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Physiology/Cellbiophysics, Columbia University, New York, NY

Ronan T. Swords, MD, PhD, FRCPI, FRCPath¹, Shaun Brothers, PhD^2*, Nagi Ayad, PhD^2*, Aymee Perez, PhD^3*, Justin M. Watts, MD^3*, Fernando Vargas, MD^3*, Roy Elias^3*, Ana Rodriguez^3*, Shawn Johnstone, PhD^4*, Jeffrey Albert^4*, Joseph Collard^5*, Arthur Zelent, PhD³ and Claes Wahlestedt, PhD^6*

¹Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Hospitals, Miami, FL
²1Center for Therapeutic Innovation and Department of Psychiatry and Behavioral Sciences, University of Miami, Miami
³Sylvester Comprehensive Cancer Center, University of Miami, Miami
⁴Epigenetix Inc., Delray Beach
⁵Epigenetix Inc., Miami
⁶Center for Therapeutic Innovation and Department of Psychiatry and Behavioral Sciences, University of Miami, Miami

Daniel J. DeAngelo¹, Alison R. Walker, MD², Richard F. Schlenk, MD³, Jorge Sierra⁴, Bruno C. Medeiros, MD⁵, Enrique M. Ocio^6*, Christoph Röllig^7*, Stephen A. Strickland, MD⁸, Felicitas Thol, MD⁹, Sue-zette Valera^10*, Antje Wegener^11*, Tuli De^12*, Song Mu, PhD^10*, Florence Binlich^11* and Robert K. Stuart, MD¹³

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²James Cancer Hospital, Ohio State Comprehensive Cancer Center, Columbus, OH
³University Hospital of Ulm, Ulm, Germany
⁴Department of Hematology, Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona, Barcelona, Spain
⁵Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
⁶Hospital Universitario de Salamanca, Salamanca, Spain
⁷Universitätsklinikum Carl Gustav Carus, Dresden, Germany
⁸Vanderbilt-Ingram Cancer Center, Nashville, TN
⁹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹⁰Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹¹Novartis Pharma SAS, Rueil-Malmaison, France
¹²Novartis Healthcare Pvt. Ltd., Hyderabad, India
¹³Hollings Cancer Center, Medical Univ. of South Carolina, Charleston, SC

Jose Falantes, M.D.^1*, Sylvain Thepot, MD^2*, Lisa Pleyer, MD, DI^3*, Luca Maurillo, MD^4*, Violeta Martínez-Robles, MD^5*, Raphaël Itzykson, MD, PhD⁶, Joan Bargay, MD, PhD^7*, Reinhard Stauder, MD, MSc^8,9*, Adriano Venditti, PhD¹⁰, Maria Pilar Martinez^11*, Valerie Seegers, MD^12*, Maria Angeles Foncillas, MD^13*, Sonja Burgstaller, MD^14*, Claude Gardin, MD^15*, Pau Montesinos, MD^16*, Pellegrino Musto¹⁷, Richard Greil, MD³, Miguel Sanz¹⁸, Pierre Fenaux, MD, PhD¹⁹ and Fernando Ramos, MD, PhD, MPH^20*

¹Department of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain
²Department of Blood Diseases/Hematology; CHU, Angers, France
³3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, and Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Salzburg, Austria
⁴Hematology, Fondazione Policlinico Torvergata, Roma, Italy
⁵Department of Hematology, Hospital de León, León, Spain
⁶Hematology Department, Saint-Louis Hospital, University Paris 7, Paris, France
⁷Hospital Son Llàtzer, Palma de Mallorca, Spain
⁸Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
⁹Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria
¹⁰Istituto di Ematologia, Università di Tor Vergata, Rome, Italy
¹¹Department of Hematology, Hospital Doce de Octubre, Madrid, Spain
¹²Avicenne Hospital, Paris XIII University (APHP), Bobigny, France
¹³Department of Hematology, Hospital Infanta Leonor, Madrid, Spain
¹⁴Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria
¹⁵Hematology Department, Avicenne Hospital, APHP, University Paris 13, Bobigny, France
¹⁶Hematology, Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Spain
¹⁷Hematology and Stem Cell Transplantation Unit, IRCCS, Centro Riferimento Oncologico Basilicata, Rionero in Vulture, Italy
¹⁸Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Spain
¹⁹Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
²⁰Hospital Universitario de León, León, Spain

Roman Galetto, PhD^1*, Céline Lebuhotel^1*, Agnès Gouble, PhD^1*, Nuria Mencia-Trinchant, PhD^2*, Cruz M Nicole, MD^2*, Gail J. Roboz, MD², Monica L. Guzman, PhD³ and Julianne Smith, Ph.D¹

¹Cellectis SA, Paris, France
²Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
³Division of Hematology and Medical Oncology, Department of Medicine and Department of Pharmacology, Weill Cornell Medical College, New York, NY

Timothy Pardee, MD, PhD¹, Kristin Pladna, MS^1*, Scott Isom, MS^2*, Leslie Renee Ellis, MD³, Dmitriy Berenzon, MD^4*, Dianna Howard, MD¹, Megan Manuel, MSN^1*, Sarah Dralle, MSN^1*, David D Hurd, MD¹, Susan Lyerly, PA-C^1* and Bayard L Powell, MD¹

¹Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC
²Division of Public Health Sciences, Department of Biostatistics, Comprehensive Cancer Center of Wake Forest University, Winston-Salem
³Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University, Winston Salem, NC
⁴Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University, Winston-Salem

Robert K Hills, DPhil¹, Guy Gammon, MBBS, MRCP^2*, Denise Trone^2* and Alan K. Burnett, MD, FRCP³

¹Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom
²AMBIT BIOSCIENCES, San Diego, CA
³Blackwaterfoot, Isle of Arran, United Kingdom

Samuel Koerner^1,2*, Lothar Kanz, MD², Ludger Grosse-Hovest^3*, Gundram Jung^4* and Helmut R Salih, MD^1,5

¹Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tuebingen, Tuebingen, Germany
²Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany
³Synimmune GmbH, Tuebingen, Germany, Tuebingen, Germany
⁴Department for Immunology, Eberhard Karls University, Tuebingen, Germany
⁵Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany

Juliana Vélez Luján, PhD Candidate^1,2,3*, Niki Zacharias, PhD^4*, Dinesh Rakheja, MD^5*, Tushar D Bhagat, PhD^6*, Jaehyuk Lee, PhD^4*, Prasanta Dutta, PhD^4*, Doriann Gonzalez, MD Student^7*, Michael Andreeff, MD, PhD^1*, Pratip K Bhattacharya, PhD^4*, Amit Verma, M.B., B.S.^6* and Marina Konopleva, MD, PhD¹

¹Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Programa Integral de Investigación e Innovación en Leucemia Aguda y Crónica (PILAC), Bogota, Colombia
³Department of Biochemistry, Pontificia Universidad Javeriana, Bogota, Colombia
⁴Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Departments of Pathology and Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
⁶Department of Medicine and Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY
⁷School of Medicine, University of Puerto Rico Medical Sciences Campus, Puerto Rico, PR

Jeffrey E Lancet, MD¹, Farhad Ravandi, MD², Ellen K Ritchie, MD³, Hamid Sayar, MD⁴, Stephen A. Strickland, MD⁵, Gary J Schiller, MD⁶, Norbert Vey, MD⁷, Harry P. Erba, MD, PhD⁸, Arnaud Pigneux^9*, Heinz-August Horst, MD, PhD¹⁰, Christian Recher, MD¹¹, Olatoyosi Odenike, MD¹², Angelo-Michele Carella, MD^13*, Dominik Selleslag, MD¹⁴, Jonathan Kell, MD¹⁵, Utz Krug, MD¹⁶, Leigh Page^17*, Art DeVault, PhD^17*, Shuling Hwang, MD^17*, Adam R Craig, MD, PhD¹⁷ and Robert K. Stuart, MD¹⁸

¹Moffitt Cancer Center, University of South Florida, Tampa, FL
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Weill Cornell Medical Center, New York, NY
⁴Indiana University Cancer Center, Indianapolis, IN
⁵Vanderbilt-Ingram Cancer Center, Nashville, TN
⁶University of California, Los Angeles, CA
⁷Institut Paoli-Calmettes, Marseille, France
⁸Internal Medicine, Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
⁹Hôpital Haut Lévêque-CHU de Bordeaux, Pessac, France
¹⁰Medizinische Klinik und Poliklinik im Städtischen Krankenhaus, Kiel, Germany
¹¹Hôpital Purpan-CHU de Toulouse, Toulouse, France
¹²University of Chicago, Chicago, IL
¹³IRCCS AOU San Martino-IST, Genoa, Italy
¹⁴AZ St-Jan Brugge AV, Brugge, Belgium
¹⁵University Hospital of Wales, Cardiff, United Kingdom
¹⁶Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany
¹⁷Sunesis Pharmaceuticals, Inc., South San Francisco, CA
¹⁸Medical University of South Carolina, Charleston, SC

Jasper de Boer, PhD^1*, Vanessa Walf-Vorderwuelbecke, PhD^1*, Gareth Williams, PhD^2*, Sujith Samarasinghe, MD, PhD^3*, Phil Ancliff, MD^3*, Nicholas Goulden, MD, PhD³ and Owen Williams, PhD^1*

¹Developmental Biology and Cancer Programme, UCL Institute of Child Health, London, United Kingdom
²Wolfson CARD, King's College London, London, United Kingdom
³Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom

Elizabeth F Krakow, MD, MSc, Julie Bergeron, MD, Silvy Lachance, MD, Denis-Claude Roy, MD and Jean-Sebastien Delisle, MD, PhD

Blood and Marrow Transplant Program and Division of Hematology, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada

Jonathan Allen Webster, MD¹, Raoul Tibes, MD, PhD², Amanda Blackford, ScM^3*, Lawrence Morris, MD⁴, Mrinal M Patnaik, MBBS⁵, Lihua Wang, PhD^6*, Melanie Rebechi, BS^1*, Jacqueline Greer, RN^1*, Mark R Litzow, MD⁵, Larry Karnitz, PhD^7*, Gary L. Rosner^3*, Austin Doyle, MD^8*, Scott H. Kaufmann, MD, PhD⁹, Judith E Karp, MD¹ and B. Douglas Smith, MD¹

¹Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
²Mayo Clinic Scottsdale Arizona, Scottsdale, AZ
³Johns Hopkins University, Baltimore, MD
⁴BMT Group of Georgia, Atlanta, GA
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶National Cancer Institute, Frederick, MD
⁷Mayo Clinic, Rochester, MN
⁸National Cancer Institute, Bethesda, MD
⁹Oncology Research, Mayo Clinic, Rochester, MN

C. Michel Zwaan, MD, PhD¹, Stefan Söderhäll, MD, PhD^2*, Benoit Brethon, MD^3*, Matteo Luciani, MD^4*, Carmelo Rizzari, MD^5*, David Sternberg, MD, PhD^6*, Emmanuelle Besse^7*, Catherine Dutreix, MD^8*, Franca Fagioli, MD^9*, Phoenix Ho, MD^10*, Carlo Dufour, MD¹¹ and Rob Pieters, MD, PhD^12,13

¹Department of Pediatric Hematology/Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
²Karolinska Institutet, Stockholm, Sweden
³Hôpital Robert-Debré, Paris, France
⁴IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
⁵Fondazione MBBM, Azienda Ospedaliera San Gerardo, Monza, Italy
⁶Novartis Oncology, East Hanover, NJ
⁷Novartis Oncology, Paris, France
⁸Novartis Oncology, Basel, Switzerland
⁹Regina Margherita Children's Hospital, Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Torino, Italy
¹⁰Seattle Children’s Hospital, Seattle, WA
¹¹Istituto Giannina Gaslini, Genoa, Italy
¹²Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands
¹³Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands

Claudia Arndt, PhD^1,2*, Anja Feldmann, PhD^1,2*, Stefanie Koristka, MSc^1,2*, Marc Cartellieri, PhD^2,3*, Malte von Bonin, MD^4*, Armin Ehninger, PhD^4,5*, Martin Bornhäuser, MD^6*, Gerhard Ehninger^4,5,7 and Michael P Bachmann, Prof.^1,2,5,7*

¹Institute of Radiopharmaceutical Cancer Research, HZDR Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
²Tumorimmunology, University Cancer Center (UCC), Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
³Cellex Patient Treatment GmbH, Dresden, Germany
⁴Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
⁵GEMoaB Monoclonals GmbH, Dresden, Germany
⁶Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
⁷NCT Dresden, Dresden, Germany

Eunice S. Wang, MD¹, Olga Frankfurt, MD², Keith William Orford, MD, PhD^3*, Mark Bennett, PhD³, Ian W. Flinn, MD, PhD⁴, Michael Maris, MD⁵ and Marina Konopleva, MD, PhD⁶

¹Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
²Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
³Calithera Biosciences, South San Francisco, CA
⁴Hematologic Malignancies Research Program, Sarah Cannon Research Institute, Nashville, TN
⁵Colorado Blood Cancer Institute, Denver, CO
⁶Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Hongliang Zong, MD, PhD^1*, Tony Taldone, PhD^2*, Gail J. Roboz, MD³, Gabriela Chiosis, PhD^2* and Monica L. Guzman, PhD¹

¹Division of Hematology and Medical Oncology, Department of Medicine and Department of Pharmacology, Weill Cornell Medical College, New York, NY
²Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY
³Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY